期刊
CHEMICAL BIOLOGY & DRUG DESIGN
卷 86, 期 5, 页码 1285-1291出版社
WILEY
DOI: 10.1111/cbdd.12591
关键词
HIV-1 reverse transcriptase; molecular docking; molecular dynamics; non-nucleoside reverse transcriptase inhibitor; thiazolidin-4-one
资金
- Council of Scientific and Industrial Research (CSIR), New Delhi
- Department of Science and Technology (DST), New Delhi
- Indian Council of Medical Research (ICMR), New Delhi
- ICMR
- Department of Biotechnology (DBT), New Delhi
In a focused exploration, thiazolidin-4-ones with different C-2 and N-3 substituent groups were synthesized and evaluated as non-nucleoside reverse transcriptase inhibitors against HIV-1. This has led to new active compounds sporting heteroaryls at both C-2 and N-3 positions prompting to view them in the backdrop of nevirapine. To assign the molecular attributes for the activity, the compounds are investigated by docking them into non-nucleoside inhibitor-binding pocket of HIV-1 reverse transcriptase (RT). The most active compounds of this series (7d and 7f) shared spatial features with nevirapine with added molecular flexibility. Furthermore, in molecular dynamics simulations carried out for up to 10 ns, the compounds 7d and 7f showed consistency in their interactions with non-nucleoside inhibitor-binding pocket of HIV-1 RT and suggested Tyr319 and Val106 as potential residues for H-bond interaction with these molecules. These results open new avenues for the exploration of 2,3-diheteroaryl thiazolidin-4-ones for prevention of HIV-1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据